Last reviewed · How we verify
NCT00879853
Trial of Mental Health Treatment for Darfur Refugees in Cairo
NA trial testing Interpersonal Therapy in Post-Traumatic Stress Disorder. Completed.
Quick facts
| Lead sponsor | University of California, San Francisco |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Interpersonal Therapy
Conditions studied
- Post-Traumatic Stress Disorder — all drugs for Post-Traumatic Stress Disorder →
- Depression — all drugs for Depression →
- Anger — all drugs for Anger →
- Domestic Violence — all drugs for Domestic Violence →
Sponsor
University of California, San Francisco
Who can join
18 and older, any sex, with Post-Traumatic Stress Disorder or Depression. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The enormous global burden of mental illness has been estimated through the publication of the Global Burden of Disease Study, adding momentum to refugee mental health studies (1,2). As research confirms that high levels of Posttraumatic Stress Disorder (PTSD) and depression occur in post-conflict settings, it is essential to develop effective treatment for psychological trauma in refugee populations recovering from mass violence (3-4). PTSD and depression are risk factors for anger, interpersonal discord and violence, not only among those who have trauma and depression, but also among their spouses and children (5-9). This "infectious" model of trauma/violence is critically important in the setting of ethnic conflict, as increased levels of interpersonal violence within the afflicted community hinder its recovery and fuel future cycles of conflict. To date, there has been little research on the interpersonal effects of trauma among refugee populations. The proposed research is a pilot and randomized controlled trial of "Interpersonal Therapy" (IPT) for Sudanese refugees living in Cairo. IPT, a very effective therapy for depression, has been adapted for PTSD treatment and sub-Saharan Africa settings (10-12). Measures will evaluate success of the treatment not only in terms of individual PTSD and depression symptoms, but also with respect to interpersonal conflict. Hypotheses: (1) After IPT intervention, Sudanese refugees will have lower levels of depression and trauma symptoms compared to wait list controls (2) After IPT intervention, Sudanese refugees will have lower levels of interpersonal violence compared to wait list controls.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT00879853
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Interpersonal Therapy
Trials testing the same drug.
- NCT03011801 — Reducing Fetal Exposure to Maternal Depression to Improve Infant Risk Mechanisms · NA · completed
- NCT03261050 — Target Engagement of a Novel Dissonance-Based Treatment for DSM-5 Eating Disorders · NA · completed
Other recruiting trials for Post-Traumatic Stress Disorder
Currently open trials in the same condition.
- NCT06332209 — Randomized Trial of Tele Vs. Clinic TF-CBT in Puerto Rico · NA · recruiting
- NCT06117306 — MDMA-assisted Massed Prolonged Exposure for PTSD · Phase 3 · recruiting
- NCT06002633 — Approach-Avoidance and Alcohol Challenge Study in PTSD · NA · recruiting
- NCT05254405 — An Open Label Pilot Study of IV Brexanolone for the Treatment of Post-Traumatic Stress Disorder · Phase 4 · recruiting
- NCT04152993 — Responsive Neurostimulation for Post-Traumatic Stress Disorder · EARLY_PHASE1 · recruiting
Other University of California, San Francisco trials
Trials by the same sponsor.
- NCT05284773 — Screening for Acute Malnutrition · NA · withdrawn
- NCT04634851 — Video Home Visits for Dietary Counselling · NA · not yet recruiting
- NCT06065670 — Assessing Changes in Multi-parametric MRI in Patients With Acute Demyelinating Lesions Taking Clemastine Fumarate as a M · Phase 1, PHASE2 · not yet recruiting
- NCT07534098 — Intervention for Hearing Health Among Native Americans · NA · not yet recruiting
- NCT06960421 — Exercise-based Frailty Intervention in Lung Transplantation (XFIT) · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT00879853 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of California, San Francisco
- Last refreshed: 8 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00879853.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing